VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Viatris Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$18.26−0.39 (-2.12%)

Close on Oct 19, 2026

Market cap: $21.24B
P/E (TTM): –
Dividend yield: 2.63%

Viatris Inc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Revenue	14,300	14,739	15,427	16,263	17,886	11,946	11,501	11,434
Cost of Revenue	9,286	9,116	8,988	9,766	12,311	8,149	7,603	7,432
Gross Profit	5,014	5,624	6,439	6,497	5,576	3,797	3,898	4,002
Research & Development	966	809	805	662	681	513	640	705
Selling, General & Admin	3,794	4,105	4,070	4,179	4,529	3,345	2,564	2,441
Operating Expenses	7,677	5,614	5,672	4,882	5,610	4,008	3,182	3,096
Operating Income	-2,663	10	766	1,615	-34	-211	716	906
Interest Expense	471	550	573	592	636	498	517	542
Income from Equity Investments	–	–	0	0	-62	-48	-62	-79
Other Non-Operating Income	-531	-83	9.80	1,791	5.80	-13	-44	-65
Merger & Restructuring Charges	–	–	–	–	51	51	105	–
Asset Impairment Charges	2,937	321	580	117	0	385	–	–
Gain (Loss) on Sale of Assets	-101	-400	-240	1,754	0	0	–	–
Legal Settlements	69	-351	-112	-4.40	-329	-108	21	50
Pretax Income	-3,665	-623	203	2,813	-664	-721	154	298
Income Tax Expense	-150	11	148	735	605	-51	138	-54
Net Income incl. Noncontrolling Interests	-3,515	-634	55	2,079	-1,269	-670	17	353
EPS (Basic)(per share)	-3.00	-0.53	0.05	1.71	-1.05	-1.11	0.03	0.69
EPS (Diluted)(per share)	-3.00	-0.53	0.05	1.71	-1.05	-1.11	0.03	0.68
Shares Outstanding (Basic, Weighted)(shares)	–	–	1,200	1,212	1,209	601	516	515
Shares Outstanding (Diluted, Weighted)(shares)	–	–	1,207	1,217	1,209	601	517	517
Dividend per Share(per share)	0.48	0.48	0.48	0.48	0.33	–	–	–
EBITDA	135	2,903	3,507	4,643	4,473	2,005	2,735	3,016

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 34.8%
Operating margin: -0.6%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 1.58
Debt to equity: –
Debt to assets: 38.1%
Cash to current liabilities: 14.0%

Valuation

P/E ratio: –
Price to sales: 1.44
Price to book: –
Dividend yield: 2.63%